Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B DANA

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
The Journal of the Maine Medical Association|July 1, 1976
Electrocardiographic changes during lithium therapyJ C Wren, J B Dana
Frontiers in Plant Science|February 15, 2018
Prolonged Expression of a Putative Invertase Inhibitor in Micropylar Endosperm Suppressed Embryo Growth in ArabidopsisBongeka Zuma, Mason B Dana, Dongfang Wang
American Journal of Clinical Pathology|June 1, 1976
Plasma heparin neutralizing activity. Its use in the evaluation of thrombocytopenia and thrombocytosisB Dana, A C Carvalho, L Ellman
The Journal of Cardiovascular Surgery|January 1, 1977
Plasma heparin neutralizing activity in patients with valvular stenosis and prosthetic heart valvesB Dana, L Ellman, A Carvalho, et al.
Journal of Medical Education|December 1, 1972
The community medicine clerkship: a learner-centered programK W Deuschle, S J Bosch, H D Banta, et al.
A Listing of Research in the Cardiovascular Field|February 19, 2014
SOCIAL WORK EDUCATIONE B SMITH, E BARNETT, B DANA, et al.
The American Journal of Cardiology|July 1, 1976
Plasma heparin neutralizing activity in coronary artery diseaseB Dana, L Ellman, A Carvalho, et al.
American Journal of Clinical Oncology|October 1, 1988
Evaluation of cis-platinum and DTIC combination chemotherapy in disseminated melanoma. A Southwest Oncology Group StudyW S Fletcher, S Green, J R Fletcher, et al.
Cancer|October 15, 1986
Developments in the diagnosis and treatment of primary CNS lymphoma. A prospective seriesE A Neuwelt, E P Frenkel, M K Gumerlock, et al.
Investigational New Drugs|July 1, 1989
Mitoxantrone, cisplatin, and methyl-glyoxal bis-guanylhydrazone chemotherapy for refractory malignant lymphoma: a Southwest Oncology Group phase II trialB Dana, S Dahlberg, B Schnitzer, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
The Journal of the Maine Medical Association|July 1, 1976
Electrocardiographic changes during lithium therapyJ C Wren, J B Dana
Frontiers in Plant Science|February 15, 2018
Prolonged Expression of a Putative Invertase Inhibitor in Micropylar Endosperm Suppressed Embryo Growth in ArabidopsisBongeka Zuma, Mason B Dana, Dongfang Wang
American Journal of Clinical Pathology|June 1, 1976
Plasma heparin neutralizing activity. Its use in the evaluation of thrombocytopenia and thrombocytosisB Dana, A C Carvalho, L Ellman
The Journal of Cardiovascular Surgery|January 1, 1977
Plasma heparin neutralizing activity in patients with valvular stenosis and prosthetic heart valvesB Dana, L Ellman, A Carvalho, et al.
Journal of Medical Education|December 1, 1972
The community medicine clerkship: a learner-centered programK W Deuschle, S J Bosch, H D Banta, et al.
A Listing of Research in the Cardiovascular Field|February 19, 2014
SOCIAL WORK EDUCATIONE B SMITH, E BARNETT, B DANA, et al.
The American Journal of Cardiology|July 1, 1976
Plasma heparin neutralizing activity in coronary artery diseaseB Dana, L Ellman, A Carvalho, et al.
American Journal of Clinical Oncology|October 1, 1988
Evaluation of cis-platinum and DTIC combination chemotherapy in disseminated melanoma. A Southwest Oncology Group StudyW S Fletcher, S Green, J R Fletcher, et al.
Cancer|October 15, 1986
Developments in the diagnosis and treatment of primary CNS lymphoma. A prospective seriesE A Neuwelt, E P Frenkel, M K Gumerlock, et al.
Investigational New Drugs|July 1, 1989
Mitoxantrone, cisplatin, and methyl-glyoxal bis-guanylhydrazone chemotherapy for refractory malignant lymphoma: a Southwest Oncology Group phase II trialB Dana, S Dahlberg, B Schnitzer, et al.
Pageof 3